Clinical Trials Browser

Phase 2 × Gallbladder Neoplasms × zanidatamab × Clear all

NCT04466891 2025-09-15

HERIZON-BTC-01

Phase 2 Completed

87 enrolled 25 charts 3 FDA

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms